Impaired prothrombin consumption in Bernard-Soulier syndrome is corrected in vitro by human factor VIII

Thrombosis and Haemostasis

Volumn 77, Issue 2, 1997, Pages 383-386

  Bellucci, S ^a   Girma, J P ^b   Lozano, M ^c   Meyer, D ^b   Caen, J P ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b BICÊTRE HOSPITAL   (France)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; PROTHROMBIN; VON WILLEBRAND FACTOR;

ARTICLE; BERNARD SOULIER DISEASE; BLEEDING TIME; BLOOD CLOTTING; CASE REPORT; CONTROLLED STUDY; DRUG SPECIFICITY; FIBRINOGEN BLOOD LEVEL; GIANT CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SUBENDOTHELIUM; THROMBOCYTE; THROMBOCYTE ADHESION; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 0031059826     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1655972     Document Type: Article

References (19)

1. Bernard J, Soulier JP. Sur une nouvelle variété de dystrophie thrombocytaire hémorragipare congénitale. Sem Hop Paris 1948; 97: 3217-23.
2. Nurden AT, Caen JP. Specific roles for surface glycoproteins in platelet function. Nature 1975; 255: 720-2.
3. Jamieson GA, Okumura T, Fishback B, Johnson MM, Egan JJ, Weiss HJ. Platelet membrane glycoproteins in thrombasthenia, Bernard-Soulier syndrome and storage pool disease. J Lab Clin Med 1979; 93: 652-60.
4. Clemetson KJ, Mc Gregor JL, James E, Dechavanne M, Luscher EF. Characterization of the platelet membrane glycoprotein abnormality in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high resolution two-dimensional gel electrophpresis. J Clin Invest 1982; 70: 304-11.
5. Caen J, Bellucci S. The defective prothrombin consumption in Bernard-Soulier syndrome. Hypotheses from 1948 to 1982. Blood Cells 1983; 9: 389-99.
6. Walsh PN, Mills DCB, Pareti FI, Stewart GJ, Macfarlane DE, Johnson MM, Egan JJ. Hereditary giant platelet syndrome: absence of collagen-induced coagulant activity and deficiency of factor XI binding to platelets. Brit J Haematol 1975; 29: 639-55.
7. Caen J, Lévy-Toledano S, Sultan Y, Bernard J. La dystrophie thrombocytaire hemorragipare (Interaction des plaquettes et du facteur Willebrand). Nouv Rev Fr Hematol 1973; 13: 595-602.
8. Bevers EM, Comfurius P, Nieuwenhuis K, Lévy-Toledano S, Einouf J, Bellucci S, Caen JP, Zwaal RFA. Platelet prothrombin converting activity in hereditary disorders of platelet function. Brit J Hematol 1986; 63: 335-45.
9. Bernard J, Caen JP, Maroteaux P. La dystrophie thrombocytaire hémorragipare congénitale. Revue d'Hématologie 1957; 12: 222-49.
10. Caen JP, Nurden AT, Jeanneau C, Michel H, Tobelem G, Lévy-Toledano S, Sultan Y, Valensi F, Bernard J. Bernard-Soulier syndrome, a new platelet glycoprotein abnormality: its relationship with platelet adhesion to subendothelium and with the factor VIII von Willebrand protein. J Lab Clin Med 1976; 87: 586-96.
11. Hourdille P, Pico M, Jandrot-Perrus M, Lacaze D, Lozano M, Nurden AT. Studies on the megakaryocytes of a patient with the Bernard-Soulier syndrome. Brit J Haematol 1990; 76: 521-30.
12. Simsek S, Noris P, Lozano M, Pico M, von dem Borne AEGKr, Ribera A, Gallardo D. Cys209 Ser mutation in the platelet membrane glycoprotein Iba gene is associated with Bernard-Soulier Syndrome. Brit J Haematol 1994; 88: 839-44.
13. Quick AJ, Favre-Gilly JE. The prothrombin consumption test. Blood 1949; 4: 1281-6.
14. Girma JP, Takahashi Y, Yoshioka A, Diaz J, Meyer D. Ristocetin and botrocetin involve two distinct domains of von Willebrand Factor for binding to platelet membrane glycoprotein Ib. Thromb Haemost 1990; 64: 326-32.
15. Nishino M, Girma JP, Rothschild C, Fressinaud E, Meyer D. New variant of von Willebrand disease with defective binding to Factor VIII. Blood 1989; 74: 1591-99.
16. Meyer D, Zimmerman TS, Obert B, Edgington TS. Hybridoma antibodies to human von Willebrand Factor I. Characterization of seven clones. Brit J Haematol 1984; 57: 597-608.
17. Rosing J, Tans G, Govers-Riemslag JWP, Zwaal RFA, Hemker HC. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem 1980; 255: 274-83.
18. Van Dieijen G, Tans G, Rosing J, Hemker HC. The role of phospholipid and factor VIIIa in the activation of bovine factor X. J Biol Chem 1981; 256: 3433-3442.
19. Perret B, Lévy-Toledano S, Plantavid M, Bredoux R, Chap H, Tobelem G, Douste-Blazy L, Caen JP. Abnormal phospholipid organization in Bernard-Soulier platelets. Thromb Res 1983; 31: 529-37.